Evidence map›Paper›PMID 40787258›Full record

ArticleJournal of inflammation research2025

Thyroid Hormone Pathways in Respiratory Diseases: Mechanism and Therapeutic Potential.

Elżbieta Małujło-Balcerska, Maria Gałecka, Tadeusz Pietras

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elżbieta Małujło-BalcerskaDepartment of Pneumology, Medical University of Łódź, Łódź, Poland.
Maria GałeckaMedical University of Łódź, Łódź, Poland.
Tadeusz PietrasDepartment of Clinical Pharmacology, Medical University of Łódź, Łódź, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid hormones (THs) influence a wide range of processes, from gene expression to complex signaling pathways, in almost every tissue. Over the past few years, there has been renewed interest in the TH synthesis, metabolism, secretion, and action; and the therapeutic potential of TH-related pathways and factors; as well as the mechanisms involved, including endocrine-immune/inflammatory relation. We hypothesize that TH-related factors and processes (ie, iodothyronine deiodinase, thyroid hormone transporters, etc) might influence the pathomechanism, disease course of respiratory pathology. TH-related molecules and processes may have the potential for use as indicators that may explain biological heterogeneity and/or be biomarkers of respiratory diseases. Furthermore, we postulate to explore whether the immune-inflammatory and/or other pathway components involved in lung diseases represent potential therapeutic agents. Exploration and validation of the distinctive utility of the abovementioned factors in respiratory disease should be planned and performed, paying attention to novel therapies and a panel of biomarkers, especially as the number of studies is limited and lacking, which makes it difficult to come to significant conclusions and find potential applications regarding respiratory diseases.

Indexed as

biomarkerhypothalamic-pituitary-thyroid axisiodothyronine deiodinasetherapeutic potentialthyroid hormonethyroid hormone receptorthyroid hormone transporter

Identifiers

PMID40787258
PMCPMC12334363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.